Erweiterte Suche

Yvonne L. Greenstreet gründete Highgate LLC. Derzeit ist Dr. Greenstreet President & Chief Operating Officer von Alnylam Pharmaceuticals, Inc. Dr. Greenstreet ist auch im Vorstand von Pacira Biosciences, Inc. und Mitglied der Association of the British Pharmaceutical Industry. Dr. Greenstreet war zuvor Geschäftsführerin bei Highgate LLC, Senior Vice President & Head-Medicines Development bei Pfizer Inc. und Chief Strategy-R&D, Senior Vice President bei GlaxoSmithKline Plc. Yvonne L. Greenstreet erhielt einen MBA von INSEAD und einen Bachelor-Abschluss von der University of Leeds.

Michelle M.
Greenstreet formerly worked at Citibank NA (New York), as Senior Vice President & Director-Human Resource, United Parcel Service, Inc., as Principal, Texas Workforce Commission, as Principal, Caliber Home Loans, Inc., as Chief Human Resources Officer & Executive VP from 2012 to 2014, Vericrest Financial, Inc., as Chief Human Resources Officer, and Spirit Realty Capital, Inc., as Chief Administrative Officer & Executive VP.
Ms. Greenstreet received her undergraduate degree from Texas A&M University.

Preba Greenstreet worked as a Director at Guinness Ghana Breweries Plc.

James John Pryn Greenstreet is the founder of Newmarket Capital Ltd.
which was founded in 2001 where he holds the title of Head-Corporate Finance.
He currently holds the position of Director at CityJet DAC and Electric Aviation Group Ltd.
Additionally, he is the Executive Vice President at Falko Regional Aircraft Ltd.
since 2011.
Mr. Greenstreet's former positions include being a Non-Executive Director at Powerhouse Energy Group Plc from 2021 to 2022, an Independent Non-Executive Director at Powerhouse Energy Group Plc from 2011 to 2021, and a Principal at BAE Systems Plc, IBM United Kingdom Ltd., XL Capital Assurance (UK) Ltd., and Arthur Andersen (UK).

Michael Greenstreet currently works as a Director for Easter Seals New Jersey, Inc.